Becton, Dickinson and Co. | BDX - Des Atouts





Des Atouts Changement Date
Abbott USD 110.43B 23.72B 2026-03
Agilent USD 13.07B 252M 2026-03
Align Technology USD 6.31B 80.48M 2026-03
AngioDynamics USD 269.68M 4.04M 2025-09
Avanos Medical USD 1.05B 23.6M 2026-03
Baxter International USD 19.85B 209M 2026-03
Becton, Dickinson and Co. USD 50.83B 4.01B 2026-03
Bio-Rad Laboratories USD 9.79B 786.5M 2026-03
Boston Scientific USD 44.35B 678M 2026-03
Cooper Companies USD 12.48B 58.1M 2026-03
Danaher USD 92.37B 8.82B 2026-06
Dentsply International USD 5.23B 200M 2026-03
Dexcom USD 6.63B 293.4M 2026-03
Edwards Lifesciences USD 13.32B 376M 2026-03
Globus Medical USD 5.44B 136.79M 2026-03
Insulet USD 2.99B 203.2M 2026-03
Integra LifeSciences USD 3.58B 24.28M 2026-03
Intuitive Surgical USD 20.88B 765.6M 2026-06
J&J USD 200.89B 1.68B 2026-03
Medtronic USD 91.48B 139M 2025-12
Solventum Corp USD 14.1B 197M 2026-03
Stryker USD 46.29B 1.55B 2026-03
Tandem Diabetes Care USD 1.15B 272.28M 2026-03
Teleflex USD 6.78B 164.24M 2026-03
Terumo JPY 2.31T 55.3B 2026-03
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Zimmer Biomet Holdings USD 22.72B 370.1M 2026-03